Polypharmacy in Psychiatry Practice, Volume I
Multiple Medication Use Strategies
Gebonden Engels 2013 2013e druk 9789400758049Samenvatting
Although monotherapy is generally recommended as the treatment of choice, treatment resistance of patients with psychosis, cognitive, mood and anxiety disorders represents a significant clinical problem. In this context, augmentation and combination strategies are commonly employed to address this problem. Although multiple medication use common in psychiatric practice, reasons, efficacy and safety for polypharmacy, and augmentative strategies have remained unclear. It remains unclear if there is an evidence base to support polypharmacy. Furthermore, excessive and inappropriate use of psychotropic medications has been recognized as a public health problem. This volume set is the first comprehensive, clinically oriented, reference on the multiple medication use to treat psychotic, cognitive, mood and anxiety disorders.
Specificaties
Lezersrecensies
Inhoudsopgave
Preface
Contributors
Part I. Polypharmacy treatment strategies
1. Multiple medication use in psychiatry: How Rational Can It Be? Ahsan Khan and Sheldon Preskorn
2. Receptor binding targets for antipsychotic efficacy; Maureen M. Grainger, Rebecca Ahlbrand, Paul S. Horn, Neil M. Richtand
3. Drug interactions and polypharmacy; Jessica L. Gören, and Ashley Tewksbury
4. Preclinical and clinical investigation of antipsychotic polypharmacy: What is the evidence? Dimitrios Kontis, Eirini Theochari
5. Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy? Stephen M. Stahl and Debbi A. Morrissette
6. Multiple Medication Use of Neuropsychiatry in Forensic Psychiatry: Findings from the Central State Forensic Psychiatric Hospital of Saxony-Anhalt; Joachim G. Witzel
Part II. Augmentation strategies
7. Antipsychotic treatment within a naturalistic trial - how are we treating schizophrenia patients in the "real-world"? Rebecca Schennach, Michael Obermeier, Florian Seemüller, Daniela Krause, Richard Musil, Ilja Spellmann, Hans-Jürgen Möller, Michael Riedel
8. A multi-target drug treatment in schizophrenia using adjunctive agents with non-D2 mechanisms of action; Michael S Ritsner
9. Antidepressants in schizophrenia – a place for them? Viacheslav Terevnikov and Grigori Joffe
10. Stressful life events and anticonvulsant medication in psychiatric patients; Petr Bob
11. Multiple medication use in somatic symptom disorders: from augmentation to diminution strategies; Adrian P. Mundt
Appendix; Rena Kurs
Annotated bibliography on polypharmacy
List of Psychotropic Medications
Contents to Volume II
Contributors to Volume II
Index
Rubrieken
- advisering
- algemeen management
- coaching en trainen
- communicatie en media
- economie
- financieel management
- inkoop en logistiek
- internet en social media
- it-management / ict
- juridisch
- leiderschap
- marketing
- mens en maatschappij
- non-profit
- ondernemen
- organisatiekunde
- personal finance
- personeelsmanagement
- persoonlijke effectiviteit
- projectmanagement
- psychologie
- reclame en verkoop
- strategisch management
- verandermanagement
- werk en loopbaan